Evolve FamilyReady Carrier Screen

Size: px
Start display at page:

Download "Evolve FamilyReady Carrier Screen"

Transcription

1 Evolve FamilyReady Carrier Screen Accurate & Comprehensive Expanded Carrier Screen of >200 genes for the most relevant genetic disorders for all ethnicities. Achromatopsia CNGB3 X-linked Adrenoleukodystrophy ABCD1 Alkaptonuria HGD Alpha-1 Antitrypsin Deficiency SERPINA1 Alpha-Mannosidosis MAN2B1 Alpha-Thalassemia* HBA1, HBA2 Alport Syndrome COL4A3, COL4A4 Andermann Syndrome SLC12A6 Argininosuccinate Lyase Deficiency ASL Arthrogryposis, Mental retardation, and Seizures SLC35A3 Asparagine Synthetase Deficiency ASNS Aspartylglucosaminuria AGA Ataxia with Vitamin E Deficiency TTPA Ataxia-Telangiectasia ATM Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) SACS Bardet-Biedl Syndrome, Type 1 BBS1 Bardet-Biedl Syndrome, Type 2 BBS2 Bardet-Biedl Syndrome, Type 10 BBS10 Bernard Soulier Syndrome, Type B GP1BB Bernard-Soulier Syndrome, Type C GP9 Beta-Ketothiolase Deficiency ACAT1 Beta-Thalassemia*/Sickle Cell Disease* HBB Biotinidase Deficiency BTD Bloom Syndrome* BLM Canavan Disease* ASPA Carnitine Deficiency, Primary SLC22A5 Carnitine Palmitoyltransferase IA Deficiency CPT1A Carnitine Palmitoyltransferase II Deficiency CPT2 Cartilage-Hair Hypoplasia RMRP Cerebrotendinous Xanthomatosis CYP27A1 Cholesteryl Ester Storage Disease LIPA Choreoacanthocytosis VPS13A X-linked Choroideremia CHM Chronic Granulomatous Disease CYBA Ciliary Dyskinesia, Primary 1 DNAI1 Ciliary Dyskinesia, Primary 3 DNAH5 Page 1

2 Ciliary Dyskinesia, Primary 9 DNAI2 Citrullinemia, Type 1 ASS1 Cohen Syndrome VPS13B Combined Pituitary Hormone Deficiency PROP1 Congenital Adrenal Hyperplasia CYP21A2 Congenital of Glycosylation, Type Ia PMM2 Congenital Dsorder of Glycosylation, Type Ib MPI Congenital Insensitivity to Pain with Anhidrosis NTRK1 Costeff Syndrome (a.k.a. 3-Methylglutaconic Aciduria Type 3) OPA3 Cystic Fibrosis* CFTR Cystinosis CTNS D-bifunctional Protein Deficiency HSD17B4 Dihydropyrimidine Dehydrogenase Deficiency DPYD X-linked Duchenne/Becker Muscular Dystrophy DMD Dyskeratosis Congenital RTEL1 Dysprothrombinemia F2 Ehlers-Danlos Syndrome, Type VIIC ADAMTS2 Enhanced S-cone Syndrome NR2E3 ERCC6-Related s ERCC6 ERCC8-Related s ERCC8 X-linked Fabry Disease GLA Factor XI Deficiency F11 Familial Dysautonomia* IKBKAP Familial Mediterranean Fever MEFV Fanconi Anemia, Type A FANCA Fanconi Anemia, Type C* FANCC X-linked Fragile X syndrome* FMR1 Fumarase Deficiency FH Galactosemia GALT Gaucher Disease* GBA Glaucoma, Primary Congenital CYP1B1 X-linked Glucose-6-Phosphate Dehydrogenase Deficiency G6PD Glutaric Acidemia, Type I GCDH Glycogen Storage Disease Ia (von Gierke) G6PC Glycogen Storage Disease Ib (von Gierke) SLC37A4 Glycogen Storage Disease II (Pompe) GAA Glycogen Storage Disease III (Cori/Forbes) AGL Glycogen Storage Disease IV GBE1 Glycogen Storage Disease V (McArdle) PYGM Glycogen Storage Disease VII PFKM GM1 Gangliosidosis GLB1 GRACILE Syndrome BCS1L Page 2

3 Growth Hormone Deficiency, Isolated GHRHR Gyrate Atrophy of Choroid and Retina OAT Hearing Loss, Non-syndromic TMC1 Hearing Loss, Non-syndromic (a.k.a. Connexion 26) GJB2 Hearing Loss, Non-syndromic (a.k.a. Connexion 30) GJB6 Heme Oxygenase-1 Deficiency HMOX1 Hemochromatosis HFE X-linked Hemophilia B F9 Hereditary Fructose Intolerance ALDOB Herlitz Junctional Epidermolysis Bullosa, LAMA3-Related LAMA3 Herlitz Junctional Epidermolysis Bullosa, LAMB3-Related LAMB3 Herlitz Junctional Epidermolysis Bullosa, LAMC2-Related LAMC2 Hermansky-Pudlak Syndrome 3 HPS3 Homocystinuria, CBS-deficient CBS Hydatidiform Mole, Recurrent NLRP7 Hyperinsulinism ABCC8 Hyperoxaluria, Primary Type 1 AGXT Hyperoxaluria, Primary Type 2 GRHPR Hyperoxaluria, Primary Type 3 HOGA1 Hypoaldosteronism CYP11B2 Hypohidrotic Ectodermal Dysplasia EDAR Hypophosphatasia ALPL Inclusion Body Myopathy 2 GNE Isovaleric Acidemia IVD Joubert Syndrome 2 TMEM216 Krabbe Disease GALC Limb-Girdle Muscular Dystrophy, Type 2A CAPN3 Limb-Girdle Muscular Dystrophy, Type 2B DYSF Limb-Girdle Muscular Mystrophy, Type 2C SGCG Limb-Girdle Muscular Dystrophy, Type 2D (a.k.a. Alpha-Sarcoglycanopathy) SGCA Limb-Girdle Muscular Dystrophy, Type 2E (a.k.a. Beta-Sarcoglycanopathy) SGCB Liver Failure Acute Infantile TRMU Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency HADHA Maple Syrup Urine Disease, Type 1A BCKDHA Maple Syrup Urine Disease, Type 1B BCKDHB Maple Syrup Urine Disease, Type 2 DBT Maple Syrup Urine Disease Type 3 DLD Medium Chain Acyl-CoA Dehydrogenase Deficiency ACADM Megalencephalic Leukoencephalopathy with Subcortical Cysts MLC1 Megaloblastic Anemia Syndrome SLC19A2 Metachromatic Leukodystrophy ARSA Methylmalonic Acidemia and Homocystinuria, cblc-type MMACHC Page 3

4 Methylmalonic Acidemia, cb1a-type MMAA Methylmalonic Acidemia, cb1b-type MMAB Methylmalonic Acidemia, mut-type MUT Microcephaly, Postnatal Progressive, with Seizures and Brain atrophy MED17 Microphthalmia VSX2 X-linked Mitochondrial Complex 1 Deficiency NDUFAF5, NDUFS6 Mitochondrial DNA Depletion Syndrome 1 (MNGIE type) TYMP Mucolipidosis II /IIIA GNPTAB Mucolipidosis IV* MCOLN1 Mucopolysaccharidosis, Type I IDUA X-linked Mucopolysaccharidosis, Type II IDS Mucopolysaccharidosis, Type IIIA SGSH Mucopolysaccharidosis, Type IIIB NAGLU Mucopolysaccharidosis, Type IVA GALNS Mucopolysaccharidosis, Type VI ARSB Mucopolysaccharidosis, Type VII GUSB Multiple Sulfatase Deficiency SUMF1 Muscle-Eye-Brain Disease POMGNT1 Myasthenic Syndrome, Congenital RAPSN Myopathy, Lactic Acidosis, and Sideroblastic Anemia 1 PUS1 Nemaline Myopathy NEB Nephrotic Syndrome, Type 1 (a.k.a. Finnish Nephrosis) NPHS1 Nephrotic Syndrome, Type 2 NPHS2 Neu-Laxova Syndrome 1 PHGDH Neuronal Ceroid Lipofuscinosis, Type 1 PPT1 Neuronal Ceroid Lipofuscinosis, Type 2 TPP1 Neuronal Ceroid Lipofuscinosis, Type 3 CLN3 Neuronal Ceroid Lipofuscinosis, Type 5 CLN5 Neuronal Ceroid Lipofuscinosis, Type 8 (a.k.a. Northern Epilepsy) CLN8 Niemann-Pick Disease, Type A* & B SMPD1 Niemann-Pick Disease, Type C1 NPC1 Niemann-Pick Disease, Type C2 NPC2 Nijmegen Breakage Syndrome NBN Oculocutaneous Albinism, Type 1 TYR Omenn syndrome RAG2 X-linked Ornithine Transcarbamylase Deficiency OTC Pantothenate Kinase-Associated Neurodegeneration PANK2 Papillon-Lefevre Syndrome CTSC Pendred Syndrome SLC26A4 Phenylalanine Hydroxylase Deficiency PAH Polycystic Kidney Disease, Autosomal Recessive PKHD1 Polyglandular Autoimmune Syndrome, Type 1 AIRE Page 4

5 Pontocerebellar Hypoplasia, Type 1A VRK1 Pontocerebellar Hypoplasia, Type 2D SEPSECS Pontocerebellar Hypoplasia, Type 2E VPS53 Pontocerebellar Hypoplasia, Type 6 RARS2 Progressive Pseudorheumatoid Dysplasia WISP3 Pseudocholinesterase Deficiency BCHE Pycnodysostosis CTSK Renal Tubular Acidosis with Deafness ATP6V1B1 Retinitis Pigmentosa CERKL, DHDDS, EYS, RPE65 X-linked Retinoschisis, Juvenile RS1 X-linked RETT Syndrome MECP2 Rhizomelic Chondrodysplasia Punctata, Type 1 PEX7 Salla Disease (a.k.a. Sialic Acid Storage Disease) SLC17A5 Sandhoff Disease HEXB Segawa Syndrome TH Short-Chain Acyl-CoA Dehydrogenase Deficiency ACADS Sjogren-Larsson Syndrome ALDH3A2 Skeletal Dysplasias, including Achondrogenesis, Type 1B SLC26A2 Smith-Lemli-Opitz Syndrome DHCR7 Spastic Paraplegia 49 TECPR2 Spinal Muscular Atrophy* SMN1 Tay-Sachs Disease* HEXA Thrombocytopenia MPL Tricho-Hepato-Enteric Syndrome TTC37 Tyrosinemia, Type I FAH Usher Syndrome, Type 1F PCDH15 Usher Syndrome, Type 2A USH2A Usher Syndrome, Type 3 CLRN1 Very Long Chain Acyl-CoA Dehydrogenase Deficiency ACADVL Walker Warburg Syndrome, Type 4 FKTN Werner Syndrome WRN Wilson disease ATP7B Woolly Hair/Hypotrichosis Syndrome LIPH Zellweger Spectrum s PEX1, PEX2, PEX6 *ACOG and/or ACMG recommended carrier screening for specific genetic conditions Page 5

Foresight Carrier Screen

Foresight Carrier Screen 4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 09/20/2017 Date Received: 09/22/2017 Date Tested: 09/27/2017 Indication:

More information

BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING.

BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. The Inheritest SM Carrier Screen provides relevant genetic screening for many inherited diseases found throughout the pan-ethnic US population.

More information

Foresight Carrier Screen

Foresight Carrier Screen 4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 08/17/2017 Date Received: 08/18/2017 Date Tested: 08/24/2017 Indication:

More information

SAMPLE. Carrier Screening Results Report v2.2 Page 1/8

SAMPLE. Carrier Screening Results Report v2.2 Page 1/8 MM480: Pan-Ethnic Carrier Screen - Targeted Mutation Panel Report Prepared For: Patient: Name: Date of Birth: IDs (Internal / External): Reported Gender: Reported Ethnicity: Sample: Sample Collection Date:

More information

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions: NutraHacker Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d Instructions: In this report, NutraHacker examines single nucleotide polymorphisms that reveal carrier status

More information

CHRONIC MYELOGENOUS LEUKEMIA

CHRONIC MYELOGENOUS LEUKEMIA CHRONIC MYELOGENOUS LEUKEMIA SHUFFLING THE GENETIC DECK IN CML 9 9 (q+) 22 Ph (22q-) bcr bcr-abl abl Fusion protein causes cancer GLEEVEC AND BCR-ABL FUSION PROTEIN GENETIC MEDICINE A. Genetic diseases

More information

All diseases on Foresight

All diseases on Foresight All diseases on Foresight Disease 11-Beta-Hydroxylase- Deficient Congenital Adrenal Hyperplasia 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 3-Hydroxy-3-Methylglutaryl- CoA Lyase Deficiency

More information

Foresight Carrier Screen

Foresight Carrier Screen 4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: Date Received: 02/19/2018 Date Tested: 02/26/2018 Accession ID: CSL3P6DMJ324JJ4

More information

Family Prep Screen POSITIVE: HIGH REPRODUCTIVE RISK. Cystic Fibrosis

Family Prep Screen POSITIVE: HIGH REPRODUCTIVE RISK. Cystic Fibrosis 123 Main Street Houston, TX 10231 Phone: (800) 555-1212 Fax: (800) 555-1212 FE Sample Type: OG-510 Saliva Date of Collection: 07/08/2014 Date Received: 07/13/2014 Date Tested: 07/13/2014 Indication: No

More information

Foresight Carrier Screen

Foresight Carrier Screen 321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:

More information

JOHN DOE JANE DOE. Reproductive Risk Summary. Counsyl Test Results Summary

JOHN DOE JANE DOE. Reproductive Risk Summary. Counsyl Test Results Summary Results Recipient University Medical Center 827 Attn: Dr. Paul Smith 123 Main Street Houston, TX 10231 Phone: (800) 555-1212 Fax: (800) 555-1212 NPI: 7834324983 Report Date: 09/09/2013 Female Ethnicity:

More information

Foresight Carrier Screen

Foresight Carrier Screen 321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 06/23/2017 Date Received: 06/28/2017 Date Tested: 06/28/2017 Indication:

More information

Foresight Carrier Screen

Foresight Carrier Screen 321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: EDTA Blood Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:

More information

CLINICAL AND HUMAN TESTING

CLINICAL AND HUMAN TESTING CLINICAL AND HUMAN TESTING CARRIER SCREENING FOR FAMILY PLANNING Let knowledge be your guide. Identify genetic conditions before or during a pregnancy to help predict the chances of having a child with

More information

High Impact Treatment Benefits X-Linked Moderate Impact. Disease Gene # Mutations Disease Group(s)

High Impact Treatment Benefits X-Linked Moderate Impact. Disease Gene # Mutations Disease Group(s) CarrierMap Expanded v3 Panel: 314 Diseases CarrierMap screen for 316 diseases including DMD. Disease Groups High Impact Treatment Benefits X-Linked Moderate Impact These diseases have a significant impact

More information

Foresight Carrier Screen

Foresight Carrier Screen Freiburg Medical Laboratory, ME LLC Box 3068 Dubai, 00000 Phone: +971 4 396 2227 FE Sample Type: EDTA Blood Date of Collection: 04/23/2018 Date Received: 04/27/2018 Date Tested: 05/05/2018 Indication:

More information

Results Recipient Ordering Healthcare Professional Male Details Female Details

Results Recipient Ordering Healthcare Professional Male Details Female Details Results Recipient Ordering Healthcare Professional Male Details Details Report Date /2010 Attn: Jessica Jacobson, MD Counsyl, Inc. 2200 Bridge Parkway, Suite 103 Redwood City, CA 94065 Phone: 1-888-COUNSYL

More information

Residual risks by ethnicity

Residual risks by ethnicity Residual risks by ethnicity This table displays residual risks after a negative result for each of the genes and corresponding disorders. If a patient is reported to be a carrier of a disease, their residual

More information

23andMe Reports GENETIC HEALTH RISK REPORTS. Increased risk for breast and ovarian cancer. function

23andMe Reports GENETIC HEALTH RISK REPORTS. Increased risk for breast and ovarian cancer. function 1 23andMe Reports GENETIC HEALTH RISK REPORTS BRCA1/BRCA2 Late-Onset Alzheimer's Disease Parkinson's Disease Age-Related Macular Degeneration Alpha-1 Antitrypsin Deficiency Celiac Disease G6PD Deficiency

More information

Utility of Microarrays in Molecular Genetics

Utility of Microarrays in Molecular Genetics Utility of Microarrays in Molecular Genetics Madhuri Hegde, Ph.D., FACMG Associate Professor Senior Director Department of Human Genetics Emory Genetics Laboratory Emory University School of Medicine Atlanta,

More information

4978 Santa Anita Ave Temple City, CA (p) (f)

4978 Santa Anita Ave Temple City, CA (p) (f) Patient Information Doe, Jane Sex: F MR#: FD Patient#: FT-PT00000 Accession: FT-00000 Test#: FT-00000 Specimen Type: Blood (EDTA) Collection Date: Aug 01, 2017 Partner Information Not Tested Accession:

More information

CARRIER SCREEN - LIST OF DISORDERS

CARRIER SCREEN - LIST OF DISORDERS 1 11-Beta-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 2 17-Beta-Hydroxysteroid deyhdrogenase X deficiency 3 2-Methylbutytyrglycinuria 4 21-hydroxylase deficiency 5 3-Methylcrotonyl-CoA carboxylase

More information

HERES Carrier Screening TEST

HERES Carrier Screening TEST LISTADO DE ENFERMEDADES ANALIZADAS HERES Carrier Screening TEST 11-Beta-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 17-Alpha-Hydroxylase Deficiency 17-Beta-Hydroxysteroid Dehydrogenase 3 Deficiency

More information

CarrierMap. Genetic Counseling. Technology TABLE OF. Sample Report CONTENTS. New Offerings. Recombine Facts. Disease List

CarrierMap. Genetic Counseling. Technology TABLE OF. Sample Report CONTENTS. New Offerings. Recombine Facts. Disease List Recombine 2 CarrierMap 4 Genetic Counseling TABLE OF CONTENTS 8 12 14 Technology Sample Report New Offerings 18 Recombine Facts 19 Disease List CARRIERMA ROVIDES COMLETE We help families have healthy children

More information

Comprehensive Jewish Carrier Screen

Comprehensive Jewish Carrier Screen Comprehensive Jewish Carrier Screen What is carrier screening? There are several genetic disease mutations that occur at increased frequencies in the Ashkenazi Jewish (Central & Eastern European), Sephardi

More information

Expanded carrier screening for monogenic disorders: where are we now?

Expanded carrier screening for monogenic disorders: where are we now? DOI: 10.1002/pd.5109 SPECIAL TOPIC ISSUE ON ADVANCES IN THE DIAGNOSIS OF SINGLE GENE DISORDERS Expanded carrier screening for monogenic disorders: where are we now? Davit Chokoshvili*, Danya Vears and

More information

Knowledge is power. Plan ahead with GeneAware.

Knowledge is power. Plan ahead with GeneAware. MATERNAL FETAL Many patients may have questions regarding specific genetic disorders that may arise when planning or expecting a baby. That s why Baylor Genetics developed GeneAware, a reproductive carrier

More information

The Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem

The Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem The Israeli population carrier screening program Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem The Israeli population 2015 8,134,500 inhabitants Jews (75.1%) Ashkenazi, non

More information

GENE BY GENE CARRIER SCREENING

GENE BY GENE CARRIER SCREENING Patient Copy GENE BY GENE CARRIER SCREENING GENE BY GENE CARRIER SCREEN Various genetic mutations occur with increased frequencies in various ethnic groups in the United States and around the world. For

More information

disease carrier status PANEL DETAILS VERSION Risk Details JANE MILLER JOHN MILLER NEGATIVE CARRIER * NEGATIVE MILD CONDITION NEGATIVE

disease carrier status PANEL DETAILS VERSION Risk Details JANE MILLER JOHN MILLER NEGATIVE CARRIER * NEGATIVE MILD CONDITION NEGATIVE 123 Main Street City, CA 10231 Phone: (800) 555-1212 Fax: (800) 555-1212 FE Sample Type: EDTA Blood Date of Collection: 02/06/2014 Date Received: 02/16/2014 Date Tested: 02/16/2014 Indication: Screening

More information

LABHORIZONS. New Procedures A NEWSLETTER FOR CLIENTS

LABHORIZONS. New Procedures A NEWSLETTER FOR CLIENTS LABHORIZONS A NEWSLETTER FOR CLIENTS Volume XVII, No. 7 July 2017 New Procedures 5 HIAA, Plasma.................................. 504510 CPT 83497 Synonyms 5-hydroxyindoleacetic acid Use Plasma 5-hydroxy-indoleacetic

More information

CARRIER SCREENING PANEL

CARRIER SCREENING PANEL 1 / 6 1. WHAT IS THE CARRIER? The carrier screening panel is a genetic test that simultaneously analyses mutations in 298 genes which cause recessive inherited pathologies. Diseases with a recessive inheritance

More information

23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert

23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert Table of contents Intended Use Important warnings and limitations Test performance User studies Specific test information 23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert For in-vitro

More information

NextStep Carrier Screening

NextStep Carrier Screening NextStep Carrier Screening What Is Carrier Screening? Certain genetic disorders occur more frequently in the general population, regardless of ethnic background. Carrier screening to determine if you and

More information

רשימת המחלות הנסקרות בבדיקה

רשימת המחלות הנסקרות בבדיקה רשימת המחלות הנסקרות בבדיקה By סקר גנטי טרום הריון - FamilyFirst בדיקת סקר גנטי טרום הריוני מורחב, הסוקרת כ- 850 מוטציות העלולות לחולל 255 מחלות תורשתיות. הבדיקה כוללת את כל המחלות המומלצות ע"י משרד הבריאות

More information

A Lawyer s Perspective on Genetic Screening Performed by Cryobanks

A Lawyer s Perspective on Genetic Screening Performed by Cryobanks A Lawyer s Perspective on Genetic Screening Performed by Cryobanks As a lawyer practicing in the area of sperm bank litigation, I have, unfortunately, represented too many couples that conceived a child

More information

The Counsyl Foresight Carrier Screen

The Counsyl Foresight Carrier Screen The Counsyl Foresight Carrier Screen 180 Kimball Way South San Francisco, CA 94080 www.counsyl.com contact@counsyl.com (888) COUNSYL The Counsyl Foresight Carrier Screen - Disease Reference Book 11-beta-hydroxylase-deficient

More information

23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert

23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert Table of contents Intended Use Important warnings and limitations Test performance User studies Specific test information 23andMe Personal Genome Service (PGS) Carrier Status Tests Package Insert For in-vitro

More information

LEADERS IN GENETIC FERTILITY SCREENING TM. #1 in Genetic Fertility Screening SCREEN TODAY. PROTECT TOMORROW.

LEADERS IN GENETIC FERTILITY SCREENING TM. #1 in Genetic Fertility Screening SCREEN TODAY. PROTECT TOMORROW. #1 in Genetic Fertility Screening SCREEN TODAY. ROTECT TOMORROW. THE LEADER IN FERTILITY & RERODUCTIVE GENETIC SCREENING EvolveGene was founded by world leaders in genetics and fertility discovery, with

More information

Summary of Results CARRIER STATUS DNA INSIGHT. Result: Carrier, Heterozygote. Protected Health Information. Propionic Acidemia

Summary of Results CARRIER STATUS DNA INSIGHT. Result: Carrier, Heterozygote. Protected Health Information. Propionic Acidemia Test Results Reviewed & Approved by: Laboratory Director, Nilesh Dharajiya,.D. SAPLE REPORT CARRIER STATUS DNA INSIGHT PERSONAL DETAILS DOB Jan 1, 19XX ETHNICITY Asian ORDERING HEALTHCARE PROFESSIONAL

More information

PREDICAGEN LLC REPORT

PREDICAGEN LLC REPORT The report below is a scientific interpretation of the DNA variants (referred as RS numbers) to the customer by a third party (for example 23andMe). The report should not be considered exclusive, because

More information

Genetic Carrier Screening

Genetic Carrier Screening Genetic Carrier Screening Test Indications Carrier screening is a significant testing tool for inherited genetic conditions of prenatal care. The purpose of carrier screening is to identify couples at-risk

More information

Sperm Donor Profile. Asian American Indian African American/Black. Caucasian/White East Indian Latino/Hispanic

Sperm Donor Profile. Asian American Indian African American/Black. Caucasian/White East Indian Latino/Hispanic Sperm Donor Profile This packet is for informational purposes. All the questions have been answered by the donor and are unaltered with exception to the staff impressions, genetic screening results, and

More information

Newborn Genetic Analysis

Newborn Genetic Analysis Fulgent tics Newborn tic Analysis Newborn tic Analysis (NGA) is a highly sophisticated and sensitive genetic test that identifies DNA changes that can cause infants to develop severe or life-altering conditions.

More information

BE PROACTIVE. SCREEN TODAY. PROTECT TOMORROW.

BE PROACTIVE. SCREEN TODAY. PROTECT TOMORROW. BE PROACTIVE. SCREEN TODAY. PROTECT TOMORROW. THE LEADER IN FERTILITY & REPRODUCTIVE GENETIC SCREENING EvolveGene was founded by world leaders in preventive and personalized healthcare, with over 25 years

More information

Expanded Carrier Screen (ECS)

Expanded Carrier Screen (ECS) Expanded Carrier Screen (ECS) What is carrier screening? Certain genetic disorders occur more frequently in the general population, regardless of ethnic background. Carrier screening to determine if you

More information

PATIENT EDUCATION. carrier screening INFORMATION

PATIENT EDUCATION. carrier screening INFORMATION PATIENT EDUCATION carrier screening INFORMATION carrier screening AT A GLANCE Why is carrier screening recommended? Carrier screening is one of many tests that can help provide information to you and your

More information

Sema4 Natalis. Clinical significance of panel. Testing methods, sensitivity, and limitations

Sema4 Natalis. Clinical significance of panel. Testing methods, sensitivity, and limitations Sema4 Natalis Clinical significance of panel Sema4 has designed and validated Natalis, a supplemental newborn screening panel offered for newborns, infants, and young children. This test may be offered

More information

Metabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen

Metabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen Metabolic Disorders ed Overseas but not ed in Australia Biotinidase Deficiency Severe form causes seizures & delay Biotin can prevent complications NZ, USA Tyrosinaemia Type I Coma & death before age 10

More information

INVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS

INVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS INVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS A broad menu covering the vast majority of inherited metabolic disorders that are routinely tested as part of state newborn screening

More information

A. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia

A. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia OMIM # FULL NAME A. disorders of amino acid metabolism 1 261600 classical phenylketonuria and hyperphenylalaninemia 2 261640 phenylketonuria due to PTPS deficiency 3 261630 phenylketonuria due to DHPR

More information

LMM / emerge III Network Reference Sequences October 2016 LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene

LMM / emerge III Network Reference Sequences October 2016 LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene ACTA2* Exon 02-09 NM_001613.2 DSG2* Exon 01-15 NM_001943.3 ACTC1* Exon 01-06 NM_005159.4 DSP* Exon 01-24 NM_004415.2 APC* Exon 01-15

More information

Donor xytex.com

Donor xytex.com Donor 5472 Information displayed in this profile is provided by the donor. Blank fields are intentional and indicate that the information is not available. xytex.com info@xytex.com 706-733-0130 General

More information

PGD: A Celebration of 20 years:

PGD: A Celebration of 20 years: PGD: A Celebration of 20 years: What is Reality and What is Not? Roma June 30, 2010 Mark Hughes, M.D., Ph.D. Professor of Genetics, Internal Medicine, Pathology Director, Genesis Genetics Institute Director,

More information

Centers for Medicare and Medicaid Services

Centers for Medicare and Medicaid Services Centers for Medicare and Medicaid Services Clinical Laboratory Fee Schedule Annual Laboratory Public Meeting June 25, 2018 Anthony Sireci, MD, Msc Association for Molecular Pathology Outline Germline Procedures

More information

Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database

Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database Coincide nce Expected coincidence Maximum possible comorbidity Disease1 Disease2 Link(KEGG)

More information

BabyNEXT TM EXTENDED. Geni investigati e patologie associate. Gene Disease OMIM gene Familial hyperinsulinism ABCC8-related

BabyNEXT TM EXTENDED. Geni investigati e patologie associate. Gene Disease OMIM gene Familial hyperinsulinism ABCC8-related Geni investigati e patologie associate BabyNEXT TM EXTENDED Gene Disease OMIM gene ABCC8 Familial hyperinsulinism ABCC8-related OMIM Disease Condition 600509 256450 Metabolic disorder - ABCD1 Adrenoleukodystrophy

More information

Newborn Screening: Focus on Treatment

Newborn Screening: Focus on Treatment Newborn Screening: Focus on Treatment Alan R. Fleischman, M.D. Senior Vice President and Medical Director March of Dimes National Conference of State Legislatures July 21, 2008 Newborn Screening: A Public

More information

Our partners worldwide. CENTOGENE Report: Diagnosed cases of rare diseases at CENTOGENE. January 2012 to June 2016.

Our partners worldwide. CENTOGENE Report: Diagnosed cases of rare diseases at CENTOGENE. January 2012 to June 2016. CENTOGENE Report: cases of rare diseases at CENTOGENE January 202 to June 206 Elucidating the basis for the link between the clinical phenotype and genotype correlation, and the factors contributing to

More information

Further expansion of the neonatal screening panel in the Netherlands

Further expansion of the neonatal screening panel in the Netherlands Further expansion of the neonatal screening panel in the Netherlands J.Gerard Loeber APHL-NBSGT, St.Louis (MO), USA 290216 Population Area Newborns 6.01 million 0.35:1 16.8 million 180,693 sq km 4.3:1

More information

Inherited Leukoencephalopathies

Inherited Leukoencephalopathies 3 Inherited Leukoencephalopathies Deborah L. Renaud, M.D. 1 1 Departments of Neurology and Pediatrics, Mayo Clinic, Rochester, Minnesota Semin Neurol 2012;32:3 8. Leukoencephalopathies are conditions that

More information

BE PROACTIVE. SCREEN TODAY. PROTECT TOMORROW.

BE PROACTIVE. SCREEN TODAY. PROTECT TOMORROW. BE PROACTIVE. SCREEN TODAY. PROTECT TOMORROW. THE LEADER IN FERTILITY & REPRODUCTIVE GENETIC SCREENING EvolveGene was founded by world leaders in preventive and personalized health care, with over 25 years

More information

Archived Reports Summary

Archived Reports Summary Archived Reports Summary 1 Archived Reports Summary This summary provides information that may be helpful when viewing your archived reports. The information in this document and in your reports is intended

More information

When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the

When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the Walkthrough of IEMbase When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the disclaimer, users are directed to the main page, which presents a search

More information

QUESTION. Personal Behavior History. Donor Genetic History. Donor Medical History. Family Medical History PERSONAL BEHAVIOR HISTORY. Never N/A.

QUESTION. Personal Behavior History. Donor Genetic History. Donor Medical History. Family Medical History PERSONAL BEHAVIOR HISTORY. Never N/A. Donor 4576 Medical Profile S Personal Behavior History Donor Genetic History Donor Medical History Family Medical History PERSONAL BEHAVIOR HISTORY Current alcohol use: If yes, oz./week and type of alcohol:

More information

General Test Requisition Form - Biochemical and Molecular

General Test Requisition Form - Biochemical and Molecular General Test Requisition Form - Biochemical and Molecular Please complete every field and tick box clearly. PATIENT INFORMATION PATIENT SAMPLE INFORMATION Patient s First Name Patient s Last Name MM/ DD

More information

Preconceptional Test For Monogenic Diseases

Preconceptional Test For Monogenic Diseases Preconceptional Test For Monogenic Diseases Dr. José A. Horcajadas Associate Professor, U. Pablo de Olavide, Seville, Spain Research Associate Professor, EVMS, Norfolk, Virginia, US CSO, Recombine Europe,

More information

General Test Requisition Form - Biochemical and Molecular

General Test Requisition Form - Biochemical and Molecular General Test Requisition Form - Biochemical and Molecular Please complete every field and tick box clearly. PATIENT INFORMATION PATIENT SAMPLE INFORMATION Patient s First Name Patient s Last Name Middle

More information

N.I.R.M.A.N. Dr. ANIL B. JALAN (MD DCH MCPS) Test list Oct 2017

N.I.R.M.A.N. Dr. ANIL B. JALAN (MD DCH MCPS) Test list Oct 2017 Tests and Profiles Tests Method Sample Needed TAT Genetic Consultation / - All samples to be sent at 2 8 C. Counseling 1 Urine MRST - 15 ml Urine 24 hrs 2 Sr. Ammonia, Lactate, Sugar Fuji Dry Chem 2 ml

More information

Most common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.

Most common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. Newborn Screening Examination parameters: TSH-neonatal (hypothyreosis), 17-OH progesterone (AGS), galactose (galactosemia), galactose-uridyl transferase (galacto semia), biotinidase (biotinidase ), phenylalanine

More information

Diagnose a broad range of metabolic disorders with a single test, Global MAPS

Diagnose a broad range of metabolic disorders with a single test, Global MAPS PEDIATRIC Assessing or diagnosing a metabolic disorder commonly requires several tests. Global Metabolomic Assisted Pathway Screen, commonly known as Global MAPS, is a unifying test for analyzing hundreds

More information

Tabella 1: PrenatalScreen - Elenco dei geni analizzati e della malattie genetiche investigate

Tabella 1: PrenatalScreen - Elenco dei geni analizzati e della malattie genetiche investigate Tabella 1: PrenatalScreen - Elenco dei geni analizzati e della malattie genetiche investigate MALATTIA PhenoMIM GENE 1 17-alpha-hydroxylase/17,20-lyase deficiency 202110 CYP17A1 2 17-beta-hydroxysteroid

More information

For Your Baby s Health Department of Health

For Your Baby s Health Department of Health Newborn Screening For Your Baby s Health Department of Health Why is my baby tested? To help make sure your baby will be as healthy as possible. The blood test provides important information about your

More information

BULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD)

BULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD) BULGARIAN NATIONAL PLAN FOR RARE DISEASES 2009 2013 Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD) Strategy for rare diseases in Bulgaria Project of National

More information

ORIGINAL RESEARCH ARTICLE

ORIGINAL RESEARCH ARTICLE American College of Medical Genetics and Genomics Open An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals

More information

GeneScreen : Elenco dei geni analizzati e malattie genetiche investigate

GeneScreen : Elenco dei geni analizzati e malattie genetiche investigate GeneScreen : Elenco dei geni analizzati e malattie genetiche investigate DISEASE NAME PhenoMIM GENE 1 17-alpha-hydroxylase/17,20-lyase deficiency 202110 CYP17A1 2 17-beta-hydroxysteroid dehydrogenase X

More information

Coagulation factor VII deficiency. Hemophilia A (German Shepherd Dog, type 1) Pyruvate kinase deficiency (Labrador Retriever type)

Coagulation factor VII deficiency. Hemophilia A (German Shepherd Dog, type 1) Pyruvate kinase deficiency (Labrador Retriever type) Blood and Clotting Coagulation factor VII deficiency Elliptocytosis Hemophilia A (German Shepherd Dog, type 2) Pyruvate kinase deficiency (Labrador Retriever type) Thrombopathia (American Eskimo Dog type)

More information

Strand Neuromuscular Disorders Test: Genes & Test Selection

Strand Neuromuscular Disorders Test: Genes & Test Selection 1 Strand Neuromuscular Disorders Test: Genes & Test Selection 2 Can the Strand Neuromuscular Disorders Test Be Offered for Prenatal Diagnosis? 3 Strand Neuromuscular Disorders Test: Genes & Test Selection

More information

Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy

Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy Alan R. Fleischman, M.D. Senior Vice President and Medical Director Chair, Federal Advisory Committee,

More information

Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)

Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) 1) Argininosuccinic acidemia (ASA) a) Incidence: ~1 in 70,000 b) Deficiency in an enzyme of

More information

COMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS

COMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS COMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS S MELDAU, G VAN DER WATT INHERITED METABOLIC DISEASES GROUP UCT /

More information

Related Policies None

Related Policies None Medical Policy MP 2.04.107 BCBSA Ref. Policy: 2.04.107 Last Review: 04/30/2018 Effective Date: 04/30/0218 Section: Medicine Related Policies None DISCLAIMER Our medical policies are designed for informational

More information

COMPLETE LIST OF GENETIC ANALYSES

COMPLETE LIST OF GENETIC ANALYSES Aarskog-Scott syndrome Achondroplasia Achromatopsia Acromesomelic dysplasia, Maroteaux type Adenosine deaminase deficiency Adrenoleukodystrophy Aicardi-Goutieres syndrome Alagille syndrome Albinism Alkaptonuria

More information

Sequencing in Newborn Screening Introduction and Background

Sequencing in Newborn Screening Introduction and Background Sequencing in Newborn Screening Introduction and Background Suzanne Cordovado, PhD Newborn Screening and Molecular Biology Branch Division of Laboratory Sciences Centers for Disease Control and Prevention

More information

Positive Newborn Screens: What do you do next?

Positive Newborn Screens: What do you do next? Positive Newborn Screens: What do you do next? James B. Gibson, MD, Ph.D. Biochemical Geneticist at Specially for Children Clinical Associate Professor of Pediatrics UTHSCSA Carla R. Scott, MD Pediatric

More information

FRAMBU. Resource Centre for Rare Disorders

FRAMBU. Resource Centre for Rare Disorders FRAMBU Resource Centre for Rare Disorders Frambu Resource Centre for Rare Disorders is one of nine centres working with rare disorders in Norway. All nine centres are part of the Norwegian National Advisory

More information

Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015

Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015 Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015 Metabolic birth defects can cause physical problems, mental retardation and, in some cases, death. It is

More information

Variant annotation Extracted variants listed in dbsnp, OMIM, ClinVar, and HGMD 2434 variants

Variant annotation Extracted variants listed in dbsnp, OMIM, ClinVar, and HGMD 2434 variants Whole Genome Sequencing and Variant Calling Whole genome sequencing and variant calling of 128 healthy Ashkenazi Jews carried out by Complete Genomics. Merged 128 genomes using CGA tools, obtained 273250

More information

Should Universal Carrier Screening be Universal?

Should Universal Carrier Screening be Universal? Should Universal Carrier Screening be Universal? Disclosures Research funding from Natera Mary E Norton MD University of California, San Francisco Antepartum and Intrapartum Management June 15, 2017 Burden

More information

QHerit Expanded Carrier Screen

QHerit Expanded Carrier Screen QHerit Expanded Carrier Screen Test Code: 94372 (X) Specimen Requirements: Preferred: 6 ml (4 ml minimum) room-temperature whole blood: 1.5 ml (1 ml minimum) in each of 4 lavender-top (EDTA) or yellow-top

More information

Neurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018

Neurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018 Neurodegenerative disorders: an approach to investigation Robert Robinson Practical Paediatric Neurology Study Days April 2018 Aims An approach to investigating and diagnosing young children with progressive

More information

Results for Trendy. Explanation of Results

Results for Trendy. Explanation of Results Canine HealthCheck Results for Trendy Trendy's genetic health profile: Trendy's appearance profile: Trendy is not at-risk for any of the diseases tested Trendy is a Female Trendy is not a carrier for any

More information

Title: Assessing Recommendations Related To Timeliness of Newborn Screening

Title: Assessing Recommendations Related To Timeliness of Newborn Screening Title: Assessing Recommendations Related To Timeliness of Newborn Screening Purpose: In January 2014, the Secretary s Discretionary Advisory Committee on Heritable Diseases on Newborns and Children (Committee)

More information

What s New in Newborn Screening?

What s New in Newborn Screening? What s New in Newborn Screening? Funded by: Illinois Department of Public Health Information on Newborn Screening Newborn screening in Illinois is mandated and administered by the Illinois Department of

More information

Results for Farrah. These tests were developled and performed by Paw Print Genetics, Spokane WA. Explanation of Results

Results for Farrah. These tests were developled and performed by Paw Print Genetics, Spokane WA. Explanation of Results Canine HealthCheck Results for Farrah Farrah's demographic profile: Call Name: Farrah Registered Name: Amber Bear's She's All That Breed: Collie Sex: Female Age: 1 Owner: Registration #: DN44645703 Microchip/Tattoo:

More information

MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES NEWBORN SCREENING Protecting your newborn MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES [ 1 ] NEWBORN SCREENING [ 2 ] FREQUENTLY ASKED QUESTIONS [ 4 ] DISORDERS INCLUDED IN NEWBORN SCREENING [ 12 ]

More information

HEREDITARY METABOLIC DISEASES

HEREDITARY METABOLIC DISEASES HEREDITARY METABOLIC DISEASES Particular risk factors are: Advanced maternal age (e.g. Down's syndrome) Family history of inherited diseases (e.g. fragile X syndrome, Huntington's chorea) Previous child

More information

Cytogenetic Biochemical

Cytogenetic Biochemical Diagnostic Laboratories Test Menu Molecular Cytogenetic Biochemical Table of Contents Lab Directors & Genetic Counselors...2 Molecular Diagnostic Lab Next Generation Sequencing Panels...3 Biochemical Diagnostic

More information

7 Medical Genetics. Hemoglobinopathies. Hemoglobinopathies. Protein and Gene Structure. and Biochemical Genetics

7 Medical Genetics. Hemoglobinopathies. Hemoglobinopathies. Protein and Gene Structure. and Biochemical Genetics SESSION 7 Medical Genetics Hemoglobinopathies and Biochemical Genetics J a v a d F a s a J a m s h i d i U n i v e r s i t y o f M e d i c a l S c i e n c e s, N o v e m b e r 2 0 1 7 Hemoglobinopathies

More information

Approach to diagnosis of metabolic diseases

Approach to diagnosis of metabolic diseases Translational Science of Rare Diseases 1 (2016) 3 22 DOI 10.3233/TRD-160001 IOS Press 3 Approach to diagnosis of metabolic diseases Enid Gilbert-Barness a,b and Philip M. Farrell c,d, a Department of Pathology,

More information